Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|May 3, 2005
MT FdR: a ferredoxin reductase from M. tuberculosis that couples to MT CYP51Allison Zanno, Nicholas Kwiatkowski, Alfin D N Vaz, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8John M Hatcher, Eric S Wang, Liv Johannessen, et al.
Molecular Oncology|September 18, 2014
Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell linesAntonio Calles, Nicholas Kwiatkowski, Bernard K Cammarata, et al.
Nature Reviews. Cancer|October 22, 2021
Targeting transcription cycles in cancerStephin J Vervoort, Jennifer R Devlin, Nicholas Kwiatkowski, et al.
Molecular Biosystems|June 8, 2012
Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopyZijuan Zhang, Nicholas Kwiatkowski, Hong Zeng, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failureLaurent Sansregret, Charles Vadnais, Julie Livingstone, et al.
ACS Medicinal Chemistry Letters|March 18, 2011
Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1Xianming Deng, Qingkai Yang, Nicholas Kwiatkowski, et al.
ACS Chemical Biology|October 14, 2011
Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screenNicholas Kwiatkowski, Xianming Deng, Jinhua Wang, et al.
Antiviral Research|February 17, 2019
Identification of small molecule inhibitors targeting the Zika virus envelope proteinJared Pitts, Chih-Yun Hsia, Wenlong Lian, et al.
Frontiers in Oncology|February 24, 2022
Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in NeuroblastomaYang Gao, Marina Volegova, Nicole Nasholm, et al.
Pageof 4